Immunity to glycan α-Gal and possibilities for the control of COVID-19.
作者信息
la Fuente José de, Gortázar Christian, Cabezas-Cruz Alejandro
机构信息
SaBio. Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ronda de Toledo s/n, 13005 Ciudad Real, Spain.
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
出版信息
Immunotherapy. 2021 Feb;13(3):185-188. doi: 10.2217/imt-2020-0247. Epub 2020 Dec 14.
Abstract
摘要
相似文献
1
Immunity to glycan α-Gal and possibilities for the control of COVID-19.对聚糖α-Gal的免疫及控制新冠病毒病的可能性
Immunotherapy. 2021 Feb;13(3):185-188. doi: 10.2217/imt-2020-0247. Epub 2020 Dec 14.
2
Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.针对新型冠状病毒肺炎的保护性免疫：解读体液免疫与细胞免疫成分的证据
Travel Med Infect Dis. 2021 Jan-Feb;39:101911. doi: 10.1016/j.tmaid.2020.101911. Epub 2020 Nov 10.
3
Vaccine-induced protection in aging adults and pandemic response.疫苗诱导的老年成年人保护作用与大流行应对措施
Biochem Biophys Res Commun. 2021 Jan 29;538:218-220. doi: 10.1016/j.bbrc.2020.10.090. Epub 2020 Nov 17.
4
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.从卡介苗（BCG）看新冠病毒候选疫苗。
J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637.
5
A first probable case of SARS-CoV-2 reinfection in Colombia.哥伦比亚首例可能的新冠病毒再次感染病例。
Ann Clin Microbiol Antimicrob. 2021 Jan 12;20(1):7. doi: 10.1186/s12941-020-00413-8.
6
Covid-19 vaccines: delivering protective immunity.新冠疫苗：提供保护性免疫
BMJ. 2020 Dec 17;371:m4838. doi: 10.1136/bmj.m4838.
7
Immunology Lessons from the SARS-CoV-2 Pandemic.来自新冠疫情的免疫学经验教训。
Annu Rev Immunol. 2021 Apr 26;39:v-vii. doi: 10.1146/annurev-iy-39-030121-100001. Epub 2021 May 3.
8
Understanding protection from SARS-CoV-2 by studying reinfection.通过研究再次感染来了解对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的防护。
Nat Med. 2020 Nov;26(11):1680-1681. doi: 10.1038/s41591-020-1121-z.
9
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.用于开发 SARS-CoV-2 候选疫苗的新型疫苗生产平台。
Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24.
10
Herd immunization with childhood vaccination may provide protection against COVID-19.群体免疫接种儿童疫苗可能对预防 COVID-19 提供保护。
Acta Microbiol Immunol Hung. 2020 Sep 26;67(3):198-200. doi: 10.1556/030.2020.01207.
引用本文的文献
1
Allergic reactions associated with medically relevant arthropods.与医学相关节肢动物相关的过敏反应。
Ann Med. 2023;55(2):2286531. doi: 10.1080/07853890.2023.2286531. Epub 2023 Nov 27.
2
Serum biomarkers for nutritional status as predictors in COVID-19 patients before and after vaccination.作为预测指标的营养状况血清生物标志物在COVID-19患者疫苗接种前后的情况。
J Funct Foods. 2023 Feb;101:105412. doi: 10.1016/j.jff.2023.105412. Epub 2023 Jan 10.
3
Approaching Challenges Posed by SARS-CoV-2 Genetic Variants.应对SARS-CoV-2基因变异带来的挑战
Pathogens. 2022 Nov 23;11(12):1407. doi: 10.3390/pathogens11121407.
4
The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome.问题的关键：了解和管理α-半乳糖综合征。
Immunotargets Ther. 2022 Sep 15;11:37-54. doi: 10.2147/ITT.S276872. eCollection 2022.
5
Art-science multidisciplinary collaborations to address the scientific challenges posed by COVID-19.艺术-科学多学科合作应对 COVID-19 带来的科学挑战。
Ann Med. 2022 Dec;54(1):2535-2548. doi: 10.1080/07853890.2022.2123557.
6
Functional characterization of α-Gal producing lactic acid bacteria with potential probiotic properties.具有潜在益生菌特性的产 α-半乳糖苷酶乳酸菌的功能特征。
Sci Rep. 2022 May 6;12(1):7484. doi: 10.1038/s41598-022-11632-8.
7
Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.采用定量血清蛋白质组学对 COVID-19 症状的免疫相关预后生物标志物进行表征。
Front Immunol. 2021 Sep 8;12:730710. doi: 10.3389/fimmu.2021.730710. eCollection 2021.
8
Probiotic Bacteria with High Alpha-Gal Content Protect Zebrafish against Mycobacteriosis.富含α-半乳糖的益生菌可保护斑马鱼免受分枝杆菌病侵害。
Pharmaceuticals (Basel). 2021 Jun 30;14(7):635. doi: 10.3390/ph14070635.
本文引用的文献
1
Anti-Tick Microbiota Vaccine Impacts Performance during Feeding.抗蜱微生物群疫苗对蜱进食期间的性能有影响。
Vaccines (Basel). 2020 Nov 21;8(4):702. doi: 10.3390/vaccines8040702.
2
COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection?发展中国家的 COVID-19：α-半乳糖的免疫反应是否是减轻感染严重程度的一个被忽视的因素？
ACS Infect Dis. 2020 Dec 11;6(12):3104-3108. doi: 10.1021/acsinfecdis.0c00747. Epub 2020 Nov 12.
3
Host or pathogen-related factors in COVID-19 severity?新冠病毒肺炎严重程度中的宿主或病原体相关因素？
Lancet. 2020 Oct 31;396(10260):1396-1397. doi: 10.1016/S0140-6736(20)32215-7.
4
The antibody response to the glycan α-Gal correlates with COVID-19 disease symptoms.针对聚糖 α-Gal 的抗体反应与 COVID-19 疾病症状相关。
J Med Virol. 2021 Apr;93(4):2065-2075. doi: 10.1002/jmv.26575. Epub 2020 Oct 30.
5
α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives.基于α-半乳糖的疫苗：进展、机遇和展望。
Trends Parasitol. 2020 Dec;36(12):992-1001. doi: 10.1016/j.pt.2020.08.001. Epub 2020 Sep 15.
6
The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments.采用病毒衣壳衍生的病毒样颗粒（VLPs）进行疾病预防和治疗。
Vaccines (Basel). 2020 Aug 2;8(3):432. doi: 10.3390/vaccines8030432.
7
SARS-CoV-2 replicating in nonprimate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.在非灵长类哺乳动物细胞中复制的 SARS-CoV-2 可能由于抗 Gal 抗体而对 COVID-19 疫苗具有关键优势：一篇迷你综述及建议。
J Med Virol. 2021 Jan;93(1):351-356. doi: 10.1002/jmv.26312. Epub 2020 Aug 2.
8
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
9
A Critical Needs Assessment for Research in Companion Animals and Livestock Following the Pandemic of COVID-19 in Humans.人类 COVID-19 大流行后伴侣动物和家畜研究的关键需求评估。
Vector Borne Zoonotic Dis. 2020 Jun;20(6):393-405. doi: 10.1089/vbz.2020.2650. Epub 2020 May 5.
10
Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis.在斑马鱼结核病模型中，用α-半乳糖进行疫苗接种可预防分枝杆菌感染。
Vaccines (Basel). 2020 Apr 24;8(2):195. doi: 10.3390/vaccines8020195.
Zotero 插件